PRIORI, SILVIA GIULIANA
 Distribuzione geografica
Continente #
NA - Nord America 18.899
AS - Asia 15.648
EU - Europa 11.735
SA - Sud America 2.157
AF - Africa 467
OC - Oceania 48
Continente sconosciuto - Info sul continente non disponibili 22
Totale 48.976
Nazione #
US - Stati Uniti d'America 18.523
CN - Cina 7.734
SG - Singapore 3.439
IE - Irlanda 2.610
HK - Hong Kong 1.785
UA - Ucraina 1.700
BR - Brasile 1.634
DE - Germania 1.263
IT - Italia 1.233
RU - Federazione Russa 1.201
VN - Vietnam 1.147
FI - Finlandia 921
FR - Francia 846
SE - Svezia 780
GB - Regno Unito 644
IN - India 296
CA - Canada 194
AR - Argentina 180
BD - Bangladesh 170
ZA - Sudafrica 161
JP - Giappone 152
IQ - Iraq 122
MX - Messico 117
PK - Pakistan 102
ID - Indonesia 94
TR - Turchia 92
AT - Austria 89
NL - Olanda 86
EC - Ecuador 76
PL - Polonia 70
VE - Venezuela 68
CO - Colombia 67
UZ - Uzbekistan 66
ES - Italia 63
PH - Filippine 61
MA - Marocco 59
MU - Mauritius 41
JO - Giordania 40
SA - Arabia Saudita 38
MY - Malesia 37
TN - Tunisia 36
AU - Australia 33
PY - Paraguay 33
CL - Cile 32
NP - Nepal 31
EG - Egitto 29
IR - Iran 29
KE - Kenya 28
BE - Belgio 26
IL - Israele 24
PE - Perù 24
PT - Portogallo 22
UY - Uruguay 22
AZ - Azerbaigian 21
LT - Lituania 21
AE - Emirati Arabi Uniti 20
DZ - Algeria 20
KZ - Kazakistan 19
AL - Albania 18
BO - Bolivia 17
CH - Svizzera 17
CR - Costa Rica 15
ET - Etiopia 15
TH - Thailandia 14
CZ - Repubblica Ceca 13
EU - Europa 13
JM - Giamaica 13
KR - Corea 13
SN - Senegal 13
OM - Oman 12
SK - Slovacchia (Repubblica Slovacca) 12
KW - Kuwait 10
BG - Bulgaria 9
GR - Grecia 9
NZ - Nuova Zelanda 9
PA - Panama 9
PS - Palestinian Territory 9
RO - Romania 9
LV - Lettonia 8
BA - Bosnia-Erzegovina 7
CG - Congo 7
GE - Georgia 7
HR - Croazia 7
KG - Kirghizistan 7
LB - Libano 7
RS - Serbia 7
TW - Taiwan 7
BW - Botswana 6
BY - Bielorussia 6
DK - Danimarca 6
NI - Nicaragua 6
NO - Norvegia 6
SI - Slovenia 6
XK - ???statistics.table.value.countryCode.XK??? 6
AM - Armenia 5
AO - Angola 5
BH - Bahrain 5
MD - Moldavia 5
NG - Nigeria 5
QA - Qatar 5
Totale 48.856
Città #
Dublin 2.605
Chandler 2.494
Jacksonville 2.152
Nanjing 1.747
Hong Kong 1.746
San Jose 1.710
Singapore 1.675
Ashburn 1.543
Dallas 1.324
Beijing 997
Boardman 957
Nanchang 742
Princeton 651
Lawrence 586
Lauterbourg 559
Wilmington 541
Hebei 530
Changsha 499
Shenyang 462
Ho Chi Minh City 423
Los Angeles 418
Jiaxing 376
Medford 375
Tianjin 316
Helsinki 309
Hanoi 286
San Genesio Ed Uniti 257
Buffalo 253
Hangzhou 243
Moscow 235
Milan 213
New York 208
Shanghai 206
Woodbridge 197
Redondo Beach 188
São Paulo 139
Tokyo 131
Ann Arbor 125
Verona 113
Johannesburg 110
Norwalk 107
Falls Church 94
The Dalles 92
Nuremberg 91
Falkenstein 84
Seattle 84
Orem 81
Santa Clara 76
Munich 75
Chicago 71
Frankfurt am Main 70
Guangzhou 64
Houston 64
Toronto 64
Des Moines 60
Da Nang 59
Montreal 59
Brooklyn 58
Rio de Janeiro 57
Kunming 53
London 53
Zhengzhou 51
San Francisco 50
Warsaw 50
Chennai 49
Fairfield 49
Rome 49
Tashkent 48
Council Bluffs 45
Baghdad 41
Haiphong 41
Jinan 41
Washington 41
Columbus 39
Lahore 39
Stockholm 39
Vienna 38
Amman 36
Belo Horizonte 36
Mexico City 36
Boston 31
Pavia 31
Phoenix 31
Atlanta 30
Ningbo 30
Brasília 29
Guayaquil 29
Tappahannock 29
Turku 29
Curitiba 28
Dearborn 28
Amsterdam 27
Dhaka 27
Naples 27
Salvador 27
Denver 25
Istanbul 23
Nairobi 23
Taizhou 23
Changchun 22
Totale 31.524
Nome #
Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology; ESC Committee for Practice Guidelines (CPG). Guidelines on the management of stable angina pectoris: executive summary: the Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology 279
Calcio antagonisti e aritmie da riperfusione miocardica 204
From decision to shared-decision: Introducing patients' preferences into clinical decision analysis. 182
Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease 177
A method of gene transfer for the treatment of recessive CPVT 169
Tachicardia Ventricolare Polimorfa Catecolaminergica 163
Arrhythmogenic mechanisms in a mouse model of Catecholaminergic Polymorphic Ventricular Tachycardia. 162
A cardiac arrhythmia syndrome caused by loss of ankyrin-B function 158
Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol: Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology 154
American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents; European Society of Cardiology Committee for Practice Guidelines. American college of cardiology/european society of cardiology clinical expert consensus documen on hypertrophic cardiomyopathy. A report of the american college of cardiology foundation task force on clinical expert consensus documents and the european society of cardiology committee for practice guidelines 151
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC 149
2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/ American Heart Association Task Force on practice guidelines. American College of Cardiology Foundation/American Heart Association Task Force. 144
Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice 143
La Sindrome di Brugada: aspetti clinici, criteri diagnostici, stratificazione prognostica. 139
[Electrophysiologic features of the modulation of ATP-dependent potassium channels]. 135
[Idiopathic ventricular fibrillation: from a collection of clinical cases to a prospective evaluation. The U-CARE Steering Committee. Unexplained Cardiac Arrest Registry of Europe]. 135
La Sindrome di Brugada 131
Arrhythmogenic Right Ventricular Cardiomyopathy: Clinical Course and Predictors of Arrhythmic Risk 131
Aspetti elettrofisiologici della modulazione dei canali del potassio ATP-dipendenti 130
[2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac Death. The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology] 130
Task Force on Syncope, European Society of Cardiology.Guidelines on management (diagnosis and treatment) of syncope-update 2004. Executive Summary. 129
2010 focused update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association 129
Abnormal Calcium Signalling and Sudden Cardiac Death Associated With Mutation of Calsequestrin. 128
Natural History and Risk Stratification in Andersen-Tawil Syndrome Type 1 128
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC 127
A newly charactarized SCN5A mutation underlying Brugada Syndrome unmasked by Hyperthermia 127
Interplay Between Genetic Substrate, QTc Duration, and Arrhythmia Risk in Patients With Long QT Syndrome 126
Gene-specific therapy for inherited arrhythmogenic diseases 125
Computer simulation of wild-type and mutant human cardiac Na+ current 124
Sympathetic activation, ventricular repolarization and Ikr blockade: implications for the antifibrillatory efficacy of potassium channel blocking agents 123
Linee Guida. Task Force sulla Morte Cardiaca Improvvisa, Società Europea di Cardiologia. Riassunto delle raccomandazioni 122
Abnormal Interactions of Calsequestrin With the Ryanodine Receptor Calcium Release Channel Complex Linked to Exercise-Induced Sudden Cardiac Death 122
A Molecular Link between the Sudden Infant Death Syndrome and the Long-QT Syndrome. 122
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). 121
Hydroquinidine Prevents Life-Threatening Arrhythmic Events in Patients With Short QT Syndrome 121
2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy: Executive summary 121
Images in cardiovascular medicine. Endocardial implantation of a cardioverter-defibrillator in a 13-month-old child affected by long-QT syndrome and syndactyly. 120
Beyond Cohort Selection: An Analytics-Enabled i2b2 120
2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy 120
Evolving determinants of carotid atherosclerosis vulnerability in asymptomatic patients from the MAGNETIC observational study 120
2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death 119
European Society of Cardiology. Expert consensus document on the use of antiplatelet agents. The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European society of cardiology. 119
Allele-Specific Silencing of Mutant mRNA Rescues Ultrastructural and Arrhythmic Phenotype in Mice Carriers of the R4496C Mutation in the Ryanodine Receptor Gene (RYR2). 119
Clinical and Molecular Characterization of Patients with Catecholominergic Polymorphic Ventricular Tachycardia. 116
Task Force. Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. 116
2010 Focused Update of ESC guidelines on device therapy in heart failure: An update of the 2008 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association 116
Gene-specific therapy with mexiletine reduces arrhythmic events in patients with long QT syndrome type 3 116
Genetic causes of sudden cardiac death in the young. 116
Catecholaminergic Polymorphic Ventricular Tachycardia. 115
Risk stratification in the Long-QT Syndrome 115
SUDDEN CARDIAC DEATH 115
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC) 115
Clinical timelines development from textual medical reports in Italian 115
[2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death] 114
Molecular strategies for the electrophysiologist 113
2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association 113
FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death. 113
CARDIO-i2b2: integrating arrhythmogenic disease data in i2b2. 112
Association of Hydroxychloroquine with QTc Interval in Patients with COVID-19 112
A Recessive Variant of the Romano-Ward Long QT Syndrome 111
[Role of standard resting ECG in the assessment of sudden cardiac death risk] 111
Adrenergic Arrhythmogenesis and The Long QT syndrome 110
Unexplained cardiac arrest. The need for a prospective registry. 110
Information extraction from Italian medical reports: An ontology-driven approach 110
2015 ESC Guidelines for the Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death 110
Cost-effectiveness of Neonatal ECG as a Screening for Long QT-syndrome: A Decision Analysis Approach. 109
Increased Ca2+ Sensitivity of the Ryanodine Receptor Mutant RyR2R4496C Underlies Catecholaminergic Polymorphic Ventricular Tachycardia. 109
2015 European Society of Cardiology Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death summarized by co-chairs 109
A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene. 109
Abnormal Propagation of Calcium Waves and Ultrastructural Remodeling in Recessive Catecholaminergic Polymorphic Ventricular Tachycardia. 109
Efficacy and Limitations of Quinidine in Patients with Brugada Syndrome 109
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). 109
Task Force on Clinical Expert Consensus Documents. American College of Cardiology; Committee for Practice Guidelines. European Society of Cardiology. American college of cardiology/european society of cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the american college of cardiology foundation task force on clinical expert consensus documents and the european society of cardiology committee for practice guidelines 108
Fever-related arrhythmic events in the multicenter Survey on Arrhythmic Events in Brugada Syndrome 108
Big Data as a Driver for Clinical Decision Support Systems: A Learning Health Systems Perspective 108
A common polymorphism associated with antibiotic-induced cardiac arrhythmia 107
Survivors of out-of-hospital cardiac arrest with apparently normal heart: need for definition and standardized clinical evaluation . Consensus statement of the Joint Steering Committees of Unexpleined Cardiac Arrest Registry of Europe and of Idiophatic Ventricular Fibrillation Registry of the United States 107
CardioVAI: An automatic implementation of ACMG-AMP variant interpretation guidelines in the diagnosis of cardiovascular diseases 107
Spotlight on sudden cardiac death 106
Long QT syndrome and catecholaminergic VT 106
La sindrome di Brugada: epidemiologia, stratificazione del rischio e management clinico. 106
Clinical profile and genetic basis of Brugada syndrome in the Chinese population. 105
Genotype-Phenotype correlation in the Long QT Syndrome. Gene-specific triggers for life-threatening arrhythmias 105
Basi genetiche della morte cardiaca improvvisa 105
Universal definition of myocardial infarction. 105
Guidelines On Diabetes, Pre-Diabetes, And Cardiovascular Diseases: Executive Summary.The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). 104
Molecular genetics: is it making an impact in the management of inherited arrhythmogenic syndromes? 104
A molecular basis for the therapy of the long QT syndrome 104
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society 103
Cardiac Sodium Channel Diseases 103
An ICT infrastructure to integrate clinical and molecular data in oncology research. 103
Clinical presentation and outcome of Brugada syndrome diagnosed with the new 2013 criteria 103
Age and sex-related differences in the clinical manifestations of congenital long QT syndrome: findings from the International Prospective LQTS Registry 103
Genetics of sudden death: focus on inherited channelopathies 102
Brugada and Long QT Syndrome are two different diseases: True or False? 102
Role of the JP45-calsequestrin complex on calcium entry in slow twitch skeletal muscles 102
Molecular Bases of Juvenile Sudden Cardiac Death. 102
ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias-executive summary. a report of the American college of cardiology/American heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines (writing committee to develop guidelines for the management of patients with supraventricular arrhythmias) Developed in Collaboration with NASPE-Heart Rhythm Society 101
Calmodulin kinase II inhibition prevents arrhythmias in RyR2(R4496C+/-) mice with catecholaminergic polymorphic ventricular tachycardia. 101
CaMKII inhibition rectifies arrhythmic phenotype in a patient-specific model of catecholaminergic polymorphic ventricular tachycardia. 101
Totale 12.176
Categoria #
all - tutte 208.080
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 208.080


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.008 0 0 0 0 0 0 0 0 0 475 420 113
2021/20222.393 18 6 64 22 53 124 61 138 183 113 372 1.239
2022/20237.411 879 426 86 632 730 835 7 379 3.047 34 229 127
2023/20242.867 308 512 113 276 291 700 128 156 17 84 90 192
2024/20257.508 166 703 206 263 184 284 470 712 1.690 341 644 1.845
2025/202615.575 1.315 1.208 2.229 1.538 1.976 722 3.445 662 1.357 1.123 0 0
Totale 49.384